Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Blocking IL-17a can improve age-related smell loss in mice.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Mesalazine may help treat extensive alopecia areata effectively.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

New treatments for PCOS focus on managing symptoms and improving fertility.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Lokivetmab reduced itching in a dog with skin lymphoma.

Ecklonia cava improves the effectiveness of Diane-35 in managing PCOS symptoms.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.